Evidence map›Paper›PMID 42801549›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

A Spatiotemporal Single-Cell Atlas Uncovers Dysregulated ECM Dynamics and Septal Remodeling Arrest in Human Ventricular Septal Defects.

Xiaoyuan Zhang, Lun Zhu, Ze Sun, Ruolin Jia, Ziming Wang, Jiayao Zhao, Bohao Liu, Haiqing Xiong, Xiaowei Yu, Yanzhu Yue

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoyuan Zhang *Prenatal Diagnosis Center, Reproductive Medicine Center, Department of Cell Fate and Diseases, Jilin Provincial Key Laboratory of Women's Reproductive Health, Jilin Provincial Clinical Research Center for Birth Defect and Rare Disease, The First Hospital of Jilin University, Changchun, Jilin, China.
Lun Zhu *Prenatal Diagnosis Center, Reproductive Medicine Center, Department of Cell Fate and Diseases, Jilin Provincial Key Laboratory of Women's Reproductive Health, Jilin Provincial Clinical Research Center for Birth Defect and Rare Disease, The First Hospital of Jilin University, Changchun, Jilin, China.ORCID https://orcid.org/0009-0005-2682-2250
Ze SunPrenatal Diagnosis Center, Reproductive Medicine Center, Department of Cell Fate and Diseases, Jilin Provincial Key Laboratory of Women's Reproductive Health, Jilin Provincial Clinical Research Center for Birth Defect and Rare Disease, The First Hospital of Jilin University, Changchun, Jilin, China.
Ruolin JiaPrenatal Diagnosis Center, Reproductive Medicine Center, the First Hospital of Jilin University, Changchun, Jilin, China.ORCID https://orcid.org/0000-0003-3121-5680
Ziming WangPrenatal Diagnosis Center, Reproductive Medicine Center, Department of Cell Fate and Diseases, Jilin Provincial Key Laboratory of Women's Reproductive Health, Jilin Provincial Clinical Research Center for Birth Defect and Rare Disease, The First Hospital of Jilin University, Changchun, Jilin, China.
Jiayao ZhaoPrenatal Diagnosis Center, Reproductive Medicine Center, Department of Cell Fate and Diseases, Jilin Provincial Key Laboratory of Women's Reproductive Health, Jilin Provincial Clinical Research Center for Birth Defect and Rare Disease, The First Hospital of Jilin University, Changchun, Jilin, China.
Bohao LiuPrenatal Diagnosis Center, Reproductive Medicine Center, Department of Cell Fate and Diseases, Jilin Provincial Key Laboratory of Women's Reproductive Health, Jilin Provincial Clinical Research Center for Birth Defect and Rare Disease, The First Hospital of Jilin University, Changchun, Jilin, China.ORCID https://orcid.org/0000-0002-1070-1308
Haiqing XiongState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Xiaowei YuPrenatal Diagnosis Center, Reproductive Medicine Center, the First Hospital of Jilin University, Changchun, Jilin, China.ORCID https://orcid.org/0000-0002-1086-7930
Yanzhu YuePrenatal Diagnosis Center, Reproductive Medicine Center, Department of Cell Fate and Diseases, Jilin Provincial Key Laboratory of Women's Reproductive Health, Jilin Provincial Clinical Research Center for Birth Defect and Rare Disease, The First Hospital of Jilin University, Changchun, Jilin, China.ORCID https://orcid.org/0000-0002-6287-3398

Funding

Bethune Medical Department of Jilin University 4044450001Bethune Medical Department of Jilin University 4047330002CAMS Innovation Fund for Medical Sciences (CIFMS) 2022-I2M-1-022CAMS Innovation Fund for Medical Sciences (CIFMS) 2023-I2M-2-007CAMS Innovation Fund for Medical Sciences (CIFMS) 2025-I2M-XHXX-138Fundamental Research Funds for the Central Universities, JLU 419021425Y11Jilin Provincial Department of Science and Technology YDZJ202501ZYTS726National Key R&D Program of China 2022YFA1106200National Natural Science Foundation of China 32370873National Natural Science Foundation of China 32522028Natural Science Foundation of Jilin Province 20250101028JJNon-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2022-RC180-07The National Natural Science Foundation of China 32470884
6 · The paper itself

Abstract

Precise extracellular matrix (ECM) coordination is essential for cardiac septation, yet the molecular etiology of human isolated perimembranous ventricular septal defects (VSD) remains elusive. Here, we constructed a high-resolution single-cell transcriptomic atlas of human VSD, benchmarking the pathological state against a 7-22 week developmental trajectory. Integrating these single-cell profiles with a reference-based spatial transcriptomic map, we deconvolved the distinct molecular signatures of membranous and muscular septal regions. We found that aberrant cardiomyocyte hypertrophy operates alongside a systemic failure in the non-myocyte microenvironment. Crucially, the ECM regulatory network is dysregulated, driven by attenuated endothelial-fibroblast crosstalk and downregulated THBS1-integrin signaling. Supported by in vitro assays, this dysregulation impairs key endothelial-to-mesenchymal transition (EndoMT) programs and transcriptionally suppresses MMP2. Spatial reconstruction confirmed this maturation block compromises both septal regions, indicating a global remodeling arrest that precludes physical closure. Validated by in situ immunofluorescence and a robust correlation between reduced maternal serum MMP2 levels and defect size, our study portrays VSD as a disease driven by microenvironmental insufficiency and arrested remodeling, providing an integrative framework for understanding human cardiac dysmorphogenesis.

Indexed as

extracellular matrix remodelingheart developmentmicroenvironmental insufficiencyMMP2 (matrix metalloproteinase 2)ventricular septal defect

Identifiers

PMID42801549
PMCPMC13616362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.